Streetbeat News

Regulatory

TNXP

Tonix Pharmaceuticals (NASDAQ:TNXP) is set to file an NDA for Tonmya for fibromyalgia management in 2H 2024, with potential FDA approval in 2H 2025. This could mark the first new FDA-approved fibromyalgia drug in over 15 years, potentially sparking a market rivalry.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 12:04 pm

LGVN

Longeveron has received FDA Fast Track Designation for its investigational therapy Lomecel-B for mild Alzheimer's disease. This follows a previous RMAT designation. Phase 2a data will be presented at the Alzheimer's Association International Conference. Lomecel-B is also being evaluated for aging-related frailty and hypoplastic left heart syndrome.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 12:01 pm

HMC

MUFG

TKOMY

Honda Motor Co (NYSE:HMC) has priced its secondary share offering at a 3% discount, raising $3.16 billion. Insurers and financial firms, including Tokyo Marine Holdings Inc. (OTC:TKOMY) and Mitsubishi UFJ Financial Group Inc. (NYSE:MUFG), are selling up to 300 million shares. This move follows regulatory pressure to reduce cross-shareholdings.

Portfolio Pulse from Shivani Kumaresan

July 17, 2024 | 11:45 am

AMD

ASML

JBHT

NVDA

QQQ

SPY

Nasdaq and S&P 500 futures dropped significantly following weak forecasts from ASML and comments from Donald Trump about Taiwan's defense bill. This has led to a tech sell-off, impacting major ETFs like SPY and QQQ. Several companies, including ASML, Nvidia, AMD, and J.B. Hunt, saw notable premarket movements.

Portfolio Pulse from Shanthi Rexaline

July 17, 2024 | 11:41 am

UNCY

Unicycive Therapeutics, Inc. (NASDAQ:UNCY) has secured a U.S. patent for its kidney disease treatment UNI-494, valid until 2040. The patent covers the method of treating acute kidney injury and contrast-induced nephropathy using the UNI-494 compound.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 11:05 am

ACXP

Acurx Pharmaceuticals announced that a new patent has been granted by the United States Patent and Trademark Office (USPTO) on July 16, 2024.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 11:05 am

MNMD

MindMed has announced a new patent covering its MM120 orally disintegrating tablet, which could enhance its product portfolio and market position.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 11:04 am

BCDA

BioCardia, Inc. (NASDAQ:BCDA) has been granted a new patent for its innovative heart procedure technology, enhancing its product portfolio and shareholder value. The patent covers a method for accessing the left atrium using a multi-directional steerable catheter, which is part of the company's Morph DNA technology. This technology is crucial for various heart procedures, and the market for transseptal access systems is expected to grow significantly.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 11:04 am

ATMP

EINC

TRP

TC Energy Corporation (NYSE:TRP) faces a setback as the Tribunal overseeing its $15 billion NAFTA damages claim ruled it cannot proceed. The decision is based on the USMCA replacing NAFTA, which limits protection to breaches before July 1, 2020. TRP shares are trading slightly lower premarket.

Portfolio Pulse from Lekha Gupta

July 17, 2024 | 10:56 am

YGMZ

MingZhu Logistics has regained compliance with Nasdaq's listing rule by curing its bid price deficiency.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 10:27 am